Certified by Founder Lodge
Avoro Capital Advisors
United States - New York
INVESTOR
1 Disclosed Funding Rounds $135,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Global life sciences firm focused on investments in biotechnology and specialty therapeutics.
| Company | Date | Round | Raised |
|---|---|---|---|
 Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
 Vicebio |
September, 24 ,2024 | Series B | $100,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
